Annual Current Liabilities
$19.86 M
+$7.91 M+66.13%
December 31, 2023
Summary
- As of February 7, 2025, KYTX annual total current liabilities is $19.86 million, with the most recent change of +$7.91 million (+66.13%) on December 31, 2023.
- During the last 3 years, KYTX annual current liabilities has risen by +$3.93 million (+24.68%).
- KYTX annual current liabilities is now at all-time high.
Performance
KYTX Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$30.98 M
+$7.51 M+31.97%
September 30, 2024
Summary
- As of February 7, 2025, KYTX quarterly total current liabilities is $30.98 million, with the most recent change of +$7.51 million (+31.97%) on September 30, 2024.
- Over the past year, KYTX quarterly current liabilities has increased by +$11.13 million (+56.02%).
- KYTX quarterly current liabilities is now at all-time high.
Performance
KYTX Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
KYTX Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +66.1% | +56.0% |
| 3 y3 years | +24.7% | +56.0% |
| 5 y5 years | +24.7% | +56.0% |
KYTX Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +66.1% | at high | +159.2% |
| 5 y | 5-year | at high | +66.1% | at high | +159.2% |
| alltime | all time | at high | +66.1% | at high | +159.2% |
Kyverna Therapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $30.98 M(+32.0%) |
| Jun 2024 | - | $23.48 M(+7.4%) |
| Mar 2024 | - | $21.86 M(+10.1%) |
| Dec 2023 | $19.86 M | $19.86 M(+17.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $16.87 M(+41.2%) |
| Dec 2022 | $11.95 M(-24.9%) | - |
| Dec 2022 | - | $11.95 M |
| Dec 2021 | $15.93 M | - |
FAQ
- What is Kyverna Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Kyverna Therapeutics?
- What is Kyverna Therapeutics annual current liabilities year-on-year change?
- What is Kyverna Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Kyverna Therapeutics?
- What is Kyverna Therapeutics quarterly current liabilities year-on-year change?
What is Kyverna Therapeutics annual total current liabilities?
The current annual current liabilities of KYTX is $19.86 M
What is the all time high annual current liabilities for Kyverna Therapeutics?
Kyverna Therapeutics all-time high annual total current liabilities is $19.86 M
What is Kyverna Therapeutics annual current liabilities year-on-year change?
Over the past year, KYTX annual total current liabilities has changed by +$7.91 M (+66.13%)
What is Kyverna Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of KYTX is $30.98 M
What is the all time high quarterly current liabilities for Kyverna Therapeutics?
Kyverna Therapeutics all-time high quarterly total current liabilities is $30.98 M
What is Kyverna Therapeutics quarterly current liabilities year-on-year change?
Over the past year, KYTX quarterly total current liabilities has changed by +$11.13 M (+56.02%)